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Abstract
Background: Older people living in care homes are particularly susceptible to infections and antibiotics are
therefore used frequently for this population. However, there is limited information on antibiotic prescribing in this
setting. This study aimed to investigate the frequency, patterns and risk factors for antibiotic prescribing in a large
chain of UK care homes.
Methods: Retrospective cohort study of administrative data from a large chain of UK care homes (resident and care
home-level) linked to individual-level pharmacy data. Residents aged 65 years or older between 1 January 2016 and
31 December 2017 were included. Antibiotics were classified by type and as new or repeated prescriptions. Rates of
antibiotic prescribing were calculated and modelled using multilevel negative binomial regression.
Results: 13,487 residents of 135 homes were included. The median age was 85; 63% residents were female. 28,689
antibiotic prescriptions were dispensed, the majority were penicillins (11,327, 39%), sulfonamides and trimethoprim
(5818, 20%), or other antibacterials (4665, 16%). 8433 (30%) were repeat prescriptions. The crude rate of antibiotic
prescriptions was 2.68 per resident year (95% confidence interval (CI) 2.64–2.71). Increased antibiotic prescribing was
associated with residents requiring more medical assistance (adjusted incidence rate ratio for nursing opposed to
residential care 1.21, 95% CI 1.13–1.30). Prescribing rates varied widely by care home but there were no significant
associations with the care home-level characteristics available in routine data.
Conclusions: Rates of antibiotic prescribing in care homes are high and there is substantial variation between
homes. Further research is needed to understand the drivers of this variation to enable development of effective
stewardship approaches that target the influences of prescribing.
Keywords: Anti-bacterial agents, Long-term care, Antibiotic stewardship, Antibiotic prescribing, care home, Older
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Background
Around one in seven people aged over 85 live in approxi-
mately 20,000 care homes in the United Kingdom [1–5].
This includes residential homes, which provide accommo-
dation and personal care, and nursing homes, in which at
least one qualified nurse is always on duty [6]. Care home
residents are at increased risk of acquiring infections
owing to age-related biological factors combined with en-
vironmental factors of the care home setting [7]. Chest
infections, gastrointestinal infections, urinary tract infec-
tions, and skin and soft tissue infections are commonly re-
ported and can cause outbreaks [7, 8].
As a result of the high frequency of symptoms that may
indicate infection, antibiotics are used frequently for care
home residents and there is potential for development of
antibiotic resistance [9, 10]. Frequent antibiotic use can be
problematic for this population because they are at in-
creased risk of adverse events related to antibiotic treat-
ment such as infection with Clostridium difficile, side
effects, and drug-drug interactions [9]. Residents admitted
to hospital frequently return to care homes and then go
back to hospital, creating the opportunity for transmission
of infections, including drug-resistant pathogens, between
healthcare settings [11]. Avoiding these adverse events re-
quires identification of opportunities to safely reduce anti-
biotic use (antibiotic stewardship). To do this, detailed
information on how antibiotics are currently used in this
setting is needed.
Current evidence on antibiotic prescribing in care
homes in the UK has largely been derived from point-
prevalence surveys, including three European Centre for
Disease Prevention and Control (ECDC)-coordinated
projects (Healthcare-associated infections in long-term
care facilities, HALT) in 2010, 2013 and 2016–17 [12–
14]. The most recent HALT survey involved care homes
in 26 countries including 70 homes in Northern Ireland,
52 in Scotland and 28 in Wales (England did not partici-
pate). The point prevalence of antibiotic use was 4.9%
across Europe and ranged from 5 to 10% in participating
UK administrations [14]. A separate UK point preva-
lence survey, conducted in 644 long-term care facilities
in 2017, found mean antibiotic prevalence of 7.7% in
nursing homes and 6.7% in residential homes, and a
mean of 1.04 antibiotics per resident [15]. Although
these surveys provide overall estimates of antibiotic use,
they are prone to seasonal variation and may not be
representative.
A recent study described antibiotic prescriptions dis-
pensed mainly to care home residents from a UK na-
tional pharmacy chain [16]. Although this study
reported that half the residents included were prescribed
at least one antibiotic per year, it did not include any
resident data (such as age, date of entry to or exit from
the care home, or date of death), precluding calculation
of person-time denominators. The study was therefore
unable to estimate rates of prescribing or assess factors
associated with high prescribing. Analyses of primary
care electronic health records have shown that prescrib-
ing increases in older age groups in the UK [17, 18].
However, these analyses provide little insight into pat-
terns of prescribing to care home residents because care
home residency is poorly recorded in UK electronic
health records.
In this study, we used linked pharmacy and adminis-
trative data to investigate antibiotic prescribing to resi-
dents of a large chain of UK care homes. Our aims were
to describe the types of antibiotics used for care home
residents, estimate the rate of antibiotic prescribing,
measure variation in prescribing by care home, and in-
vestigate care home and resident factors associated with
prescribing.
Methods
There is no mandatory surveillance system for care
homes in the UK and care home residency is not rou-
tinely recorded in electronic health records (primary or
secondary care). We therefore used administrative sys-
tems from a large chain of care homes and did a retro-
spective cohort study including residents of these homes
between 1 January 2016 and 31 December 2017. Here
we describe the data available in these systems. Care
home administrative systems were used to describe the
characteristics of residents and care homes. Individual-
level prescriptions dispensed to residents of these homes
were obtained by linkage to data from a national phar-
macy chain.
Care home administrative data
We extracted data from routine care home administra-
tive systems on resident and care home characteristics.
Resident characteristics available were: age, sex, length
of stay, residential or nursing care (i.e. at least one quali-
fied nurse on duty at all times), whether the resident had
dementia, and their status at the end of the study period
(in the home, transferred out, or died). Care home-level
characteristics available were: location, number of beds,
number of clinical and care staff, and Care Quality Com-
mission (CQC) rating (homes in England only)). We also
extracted information on suspected incidents of infec-
tion (number and type) for each resident reported dur-
ing the study period through an internal incident
monitoring system used by the care home chain. This
system is not linked to microbiological testing and there-
fore does not differentiate between suspected infections
(identified by care home staff) and those confirmed
microbiologically. We classified homes as urban or rural
and according to deprivation decile using country-
specific indices [19–25].
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Dispensed prescriptions
A large national pharmacy chain is contracted to fulfil
drug prescriptions for residents of the care home chain.
We extracted British National Formulary (BNF) drug
classifications and date dispensed from the pharmacy
database on all drugs dispensed to residents of the care
homes during the study period. We linked individual-
level pseudonymised pharmacy and resident data using
an identifier comprised of resident first initial, Soundex
(a phonetic algorithm for indexing family names by
sound), birth year, and care home identifier. Although
the pharmacy chain is contracted to dispense all drugs
to residents of the care home chain, we found that some
care homes had few residents matching to prescriptions
(suggesting that prescriptions were dispensed from else-
where). We therefore excluded data from homes for
which less than 75% of the residents had at least one
prescription (of any drug or device). As a sensitivity ana-
lysis, we included only residents for which at least one
prescription was matched (regardless of overall home
proportion). In both analyses, we also excluded residents
aged under 65 and individuals who entered and left the
care home on the same day.
This study was approved by the UCL Research Ethics
Committee (ID 11813/002).
Description of residents, care homes and antibiotics
We described resident and care home-level characteris-
tics using counts and proportions. As a simple measure
of co-morbidity, we calculated the number of chapters
of the BNF (excluding antibiotics) from which residents
had repeated drug prescriptions during the study period.
We assumed that repeated prescriptions from more
chapters would indicate a likely higher level of co-
morbidity (although this is not intended to represent an
estimate of the number of conditions).
We identified antibiotics in the pharmacy data using
BNF chapter 5 (infections) and subchapter 5.1 (antibac-
terials) [26, 27], and described antibiotic prescriptions by
class using the Anatomical Therapeutic Chemical (ATC)
system [28]. We classified antibiotics as new or repeated
prescriptions using a cut-off of 35 days: If an antibiotic
was prescribed within 35 days of a previous prescription
of the same drug, it was classified as a repeat prescrip-
tion. The 35 day cut-off was based on the distribution of
time between prescriptions of the same antibiotic (Add-
itional file 1). We calculated the total number of new
and repeat prescriptions and the median number of re-
peats for each type of antibiotic.
Estimation of antibiotic prescribing rates and factors
associated with prescribing
We described resident and care home-level characteris-
tics using counts and proportions. We calculated the
crude rate of antibiotic prescribing per resident year and
the median rate for individual residents. We plotted
rates by care home and calculated the intra-class correl-
ation coefficient.
We used multilevel negative binomial regression to
model antibiotic prescribing rates including random ef-
fects to account for clustering at the level of the care
home. We assessed single variable associations with resi-
dent- and care home-level variables and included vari-
ables that showed some association with the outcome in
a multivariable model (age and gender were also in-
cluded in multivariable models). Rural-urban classifica-
tion, deprivation decile and CQC rating are not
standardised across UK administrations. We therefore
ran separate single- and multivariable models for Eng-
land, Northern Ireland, Scotland, and Wales including
these variables in addition to those in the main regres-
sion analysis.
Analyses were conducted using R v3.5.1, using the
lme4 package for mixed effects models [29].
Results
Study population
Between 1 January 2016 and 31 December 2017, there
were 27,075 residents of the 258 care homes operated by
the chain. In 135 care homes at least 75% of residents
matched to at least one pharmacy record, with a total of
14,194 residents in these homes. A further 657 residents
were excluded because they were aged under 65 years
and 50 because they entered and left the home on the
same day. The cohort therefore included 13,487 resi-
dents of 135 care homes, who stayed for a total of 3,916,
931 resident-days (10,731 resident-years) during the
study period. Characteristics of residents and care homes
included and excluded from the main analysis were simi-
lar (Additional file 2).
Resident and care home characteristics are shown in
Table 1. Most care homes were in England (93/135,
69%), and located in urban areas (84/93, 90% care homes
in England; 17/20, 85% in Northern Ireland; 19/19, 100%
in Scotland, and 1/3, 33% in Wales). The median num-
ber of beds was 50 (range 25 to 111). The majority of
residents were female (8518/13,487, 63%) and the me-
dian age was 85 (interquartile range (IQR) 79 to 90).
Most residents had nursing care (9109/13,487, 68%),
39% (4217/13,487) had dementia, and 7027 residents
(52%) died during the study period. The median number
of BNF chapters from which residents had repeated pre-
scriptions (excluding antibiotics) was 4 (IQR 1 to 5). The
median resident length of stay during the study period
was 210 days (IQR 51 to 509) and the median total resi-
dent length of stay (from date of admission to the home)
was 333 days (IQR 67 to 913).
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Antibiotics
A total of 28,689 antibiotic prescriptions were dispensed,
and the most common ATC classes of antibiotics used
were penicillins (11,327/28,689, 39% prescriptions), sul-
fonamides and trimethoprim (5818/28,689, 20%), and
other antibacterials (4665/28,689, 16%). We classified
70% (20,223/28,689) antibiotics as new prescriptions and
30% (8466/28,689) as repeats. The prescription was a
one-off for 89% (18,002/20,223) new prescriptions, the
remaining 11% (2221/20,223) were new prescriptions
that led to repeats. When the antibiotic was repeated at
least once, the median number of antibiotic prescrip-
tions was 2 (IQR 2–3, maximum 26), and the median
number of days between the first and last prescription
was 21 (IQR 8–35). The antibiotics that were repeated
over the longest time were azithromycin, cephalexin,
nitrofurantoin and trimethoprim (Fig. 1). The median
Table 1 Resident and care home characteristics
Variable Number Percentage
Resident-level (n = 13,487)
Gender
Male 8518 63.2
Female 4969 36.8
Age
65–74 1871 13.9
75–84 5049 37.4
85–94 5691 42.2
95+ 876 6.5
Type of care
Residential 4354 32.3
Nursing 9109 67.5
Dementia
No 8246 61.1
Yes 5217 38.7
Respite care
No 11,459 85.0
Yes 2028 15.0
Length of stay during study period (days) Median
(IQR)
210 51–509
Overall length of stay (days) Median (IQR) 333 67–913
Entered care home during study period
No 5587 41.4
Yes 7900 58.6
Status at end of study period
In home 3772 28.0
Permanently Discharged 2688 19.9
Died 7027 52.1
Number of reported infection episodes during study
0 8993 66.7
1 2217 16.4
More than 1 2277 16.9
Number of BNF chapters with repeated prescriptions (excluding
antibiotics)
0–1 3907 29.0
2–4 4275 31.7
5–7 4693 34.8
8 or more 612 4.5
Care home-level (n = 135)
Country
England 93 68.9
Northern Ireland 20 14.8
Scotland 19 14.1
Wales 3 2.2
Number of beds
Table 1 Resident and care home characteristics (Continued)
Variable Number Percentage
< 40 34 25.2
40–49 37 27.4
50–59 34 25.2
60+ 30 22.2
Median overall length of stay
< 1 year 34 25.2
1–2 years 85 63.0
> 2 years 16 12.9
Clinical staff per 100 residents
< 10 35 25.9
10–19 65 48.2
20+ 35 25.9
Care staff per 100 residents
< 60 33 24.4
60–79 75 55.6
80+ 27 20.0
Percentage residents with dementia
< 10 35 25.9
10–80 80 59.3
80–100 20 14.8
Percentage residents with nursing care
< 10 20 14.8
10–80 58 43.0
80–100 57 42.2
Number of infection incidents per bed per year
Less than 1 70 51.9
1 to 2 39 28.9
2 or more 26 19.3
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number of days between the first and last prescriptions
of azithromycin was 62 (IQR 28–142).
Antibiotic prescribing rates and factors associated with
prescribing
The crude rate of prescribing was 2.68 prescriptions per
resident year (95% confidence interval (CI) 2.64–2.71).
The median rate of antibiotic prescriptions for an indi-
vidual resident per year was 0.71 (IQR 0–3.70). Rates
varied by home (median 2.67 IQR 2.07–3.29 antibiotic
prescriptions per resident year, Fig. 2), but prescribing
rates within homes were not highly correlated (intra-
class correlation coefficient 0.19).
Rates of prescribing according to resident and care
home characteristics and unadjusted results of nega-
tive binomial regression analyses are shown in Table 2
(country specific-models in Additional File 3). The
final model (Table 3) was adjusted for resident age,
sex, and variables that were associated with antibiotic
prescribing at single variable analysis: residential or
nursing care, dementia, respite care, care home entry
during study period, status at end of study period
(still in home, died, transferred out), number of infec-
tions reported, number of BNF chapters with repeat
prescriptions. In the adjusted model, increased
antibiotic prescribing was associated with care home
entry during the study period (adjusted incidence rate
ratio, aIRR 1.37, 95% CI 1.30–1.44); having nursing
care (aIRR 1.21, 95% CI 1.13–1.30); death during the
study period (aIRR 1.58, 95% CI 1.50–1.67), and those
who were permanently discharged from the home
(aIRR 1.44, 95% CI 1.32–1.57). Increased numbers of
reported infections (aIRR for two or more infections
compared to none 2.09, 95% CI 1.96–2.24) and higher
levels of co-morbidity (aIRR for 5–7 BNF chapters
with repeat prescriptions compared to 1 chapter 2.38,
95% CI 2.16–2.62; for 8 or more chapters 2.89, 95%
CI 2.54–3.28) were also associated with increased
antibiotic prescribing. There were no clear associa-
tions between antibiotic prescribing and resident age,
sex, or care home-level variables.
Sensitivity analysis
In the sensitivity analysis based on residents who had at
least one pharmacy record, 16,247 residents were in-
cluded across 235 homes. The total follow-up time was
5,178,046 resident-days (14,186 resident-years). There
were 39,809 antibiotic prescriptions, a crude rate of 2.81
antibiotic prescriptions per resident year (95% CI 2.78–
2.84). Negative binomial regression models resulted in
Fig. 1 Length of repeated antibiotic prescriptions
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similar associations to the main analysis. Full results of
sensitivity analyses are shown in Additional File 4.
Discussion
In this study of linked administrative and pharmacy data,
we have demonstrated high rates of antibiotic prescrib-
ing for care home residents with large variation by
home. There were clear associations between higher pre-
scribing and resident factors, but we found no significant
associations between prescribing rates and care home-
level characteristics. We estimated that 30% of all anti-
biotic prescriptions dispensed were repeat prescriptions.
This was the first large-scale study in the UK to esti-
mate rates of antibiotic use for care home residents. Our
estimate of 2.68 antibiotic prescriptions per resident year
is comparable to to estimates from smaller studies of
care home residents in Hampshire, England (1.99 per
resident year) [10] and South Wales (2.16 per resident
year) [30]. These estimates are higher than rates for
older adults in the general population in England derived
from primary care data, which have been estimated at
1.06 per year for those aged 65–84, [17] 1.50 per year
for those aged 85 and over, [17] and 1.13 per year for all
those aged over 65 [18]. There are few published com-
parable European or other international estimates from
care home settings. A USA study in 2001–2002 reported
a rate of 1.75 prescriptions per resident year [31]; a study
in British Columbia, Canada in 2007–2014 reported 35–
39 defined daily doses of antibiotics per 1000 resident
days [32], and a study in Ontario, Canada reported 55
antibiotic days per 1000 resident days [33]. As our study
measured rates of prescribing, and we lacked reliable in-
formation on the duration of therapy for each dispensed
antibiotic, our estimates are not directly comparable to
the HALT point prevalence surveys [12–14].
We found that higher rates of antibiotic prescribing
were associated with residents who were likely to be
more unwell, including those who had more infections,
more probable co-morbidities (defined by repeated pre-
scriptions from more BNF chapters), and those who died
or permanently moved out of the home (likely to hos-
pital) during the study period. There was also an associ-
ation between higher antibiotic prescribing and residents
who had recently moved into a home. Assuming that
Fig. 2 Crude rates and 95% confidence intervals of antibiotic prescribing by care home
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Table 2 Rates and single variable analysis of antibiotic prescribing by resident and care home characteristics
Variable Number of antibiotic
prescriptions
Resident years Antibiotic prescriptions
per resident year
Incidence rate ratio
(95% CI)
Resident-level
Gender
Male 9200 3518 2.61 Ref.
Female 19,489 7213 2.70 1.00 (0.95–1.06)
Age
65–74 3823 1507 2.54 Ref.
75–84 10,159 3955 2.57 1.02 (0.94–1.10)
85–94 12,649 4556 2.78 1.08 (1.00–1.17)
95+ 2058 713 2.89 1.16 (1.03–1.30)
Type of care
Residential 8539 3434 2.49 Ref.
Nursing 20,071 7265 2.76 1.26 (1.17–1.35)
Dementia
No 17,325 5996 2.89 Ref.
Yes 11,285 4703 2.40 0.86 (0.81–0.92)
Respite care
No 27,461 10,184 2.70 Ref.
Yes 1228 547 2.24 0.89 (0.80–0.98)
Entered care home during study period
No 17,190 6742 2.55 Ref.
Yes 11,499 3989 2.88 1.11 (1.06–1.17)
Status at end of study period
In home 10,573 4599 2.30 Ref.
Permanently Discharged 2340 906 2.58 1.14 (1.05–1.24)
Died 15,776 5226 3.02 1.47 (1.39–1.55)
Number of reported infection episodes during study
0 10,463 5405 1.94 Ref.
1 5654 2206 2.56 1.52 (1.42–1.62)
More than 1 12,572 3121 4.03 2.22 (2.07–2.37)
Number of BNF chapters with repeated prescriptions (excluding antibiotics)
0–1 852 1032 0.83 Ref.
2–4 7971 3603 2.21 1.96 (1.77–2.16)
5–7 16,390 5267 3.11 2.48 (2.25–2.73)
8 or more 3476 829 4.19 3.19 (2.81–3.62)
Care home-level
Country
England 19,206 7441 2.58 Ref.
Northern Ireland 3971 1313 3.02 1.20 (0.94–1.52)
Scotland 4526 1726 2.62 1.04 (0.82–1.31)
Wales 986 251 3.93 1.72 (0.99–3.00)
Number of beds
< 40 5708 1814 3.15 Ref.
40–49 6930 2723 2.54 0.84 (0.67–1.06)
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moving into a home is often linked to adverse health
events, this association is also likely to represent resi-
dents in more ill health. We found variation in antibiotic
prescribing rates between care homes, but this was not
explained by the care home-level factors that we were
able to investigate using routinely-collected data. This
variation indicates scope for improvement in prescribing,
and further investigation is warranted to explore the im-
portance of other individual and contextual factors that
we were not able to measure. Previous studies in care
homes have identified a range of factors that may influ-
ence prescribing behaviour including past tendency of
the physician to prescribe antibiotics [34, 35], presence
of an antimicrobial stewardship committee [36], and
practices around the use of urinary catheters [36].
We also found that a high proportion of the antibiotics
used (30%) were likely to be repeat prescriptions. The
antibiotics that were most frequently repeated for long
durations were azithromycin, cephalexin, nitrofurantoin
and trimethoprim. These antibiotics are recommended
for use as prophylaxis for chronic obstructive pulmonary
disease and urinary tract infections [37, 38]. Long-term
prophylactic use of antibiotics may therefore represent
an important opportunity for improving antibiotic stew-
ardship in care homes, particularly given that there is
limited evidence that using antibiotics as prophylaxis is
beneficial in this setting [39].
Our findings have implications for antimicrobial stew-
ardship intervention design and implementation. Re-
views of existing interventions in care homes have found
few high quality studies [40–43], and the behaviours tar-
geted by interventions are often poorly specified. We
have identified two possible targets for future behav-
ioural interventions: reducing long term prophylactic
prescriptions and optimising antibiotic use for residents
who have recently moved into a home or are near the
end of life. Our findings also highlight the need to inves-
tigate other behaviours related to stewardship that
Table 2 Rates and single variable analysis of antibiotic prescribing by resident and care home characteristics (Continued)
Variable Number of antibiotic
prescriptions
Resident years Antibiotic prescriptions
per resident year
Incidence rate ratio
(95% CI)
50–59 7378 2894 2.55 0.82 (0.65–1.04)
60+ 8673 3300 2.63 0.87 (0.68–1.11)
Median overall length of stay
< 1 year 7041 2653 2.65 Ref.
1–2 years 18,604 6952 2.68 1.02 (0.84–1.25)
> 2 years 3044 1126 2.70 1.04 (0.77–1.41)
Clinical staff per 100 residents
< 10 6941 2643 2.63 Ref.
10–19 15,143 5612 2.70 0.99 (0.81–1.22)
20+ 6605 2476 2.67 1.00 (0.79–1.26)
Care staff per 100 residents
< 60 7219 2554 2.83 Ref.
60–79 16,211 6187 2.62 0.89 (0.73–1.09)
80+ 5259 1990 2.64 0.86 (0.67–1.11)
Percentage residents with dementia
< 10 6987 2320 3.01 Ref.
10–80 18,411 7065 2.61 0.85 (0.70–1.03)
80–100 3291 1346 2.44 0.82 (0.62–1.07)
Percentage residents with nursing care
< 10 3594 1351 2.66 Ref.
10–80 13,278 5055 2.63 0.89 (0.69–1.14)
80–100 11,817 4325 2.73 1.03 (0.80–1.33)
Number of infection incidents per bed per year
Less than 1 16,329 6548 2.49 Ref.
1 to 2 8316 2887 2.88 1.14 (0.94–1.37)
2 or more 4044 1297 3.12 1.24 (0.97–1.59)
BNF British National Formulary, CI confidence interval, Ref. reference group
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precede an antibiotic being prescribed such as identify-
ing, diagnosing, escalating, and managing suspected in-
fections. Safely reducing antibiotic use in care homes
could be achieved by improved infection prevention and
control measures such as vaccination, isolation of symp-
tomatic residents, handwashing, exclusion of symptom-
atic visitors, improved catheter management, regular
movement, and good skin care [44].
A strength of this study was its large scale and use of
novel linkages between care home administrative data
and pharmacy drug dispensing data. This allowed us to
explore relationships between antibiotic prescribing rates
and resident and care home characteristics at scale for
the first time in the UK. As the majority of other esti-
mates of antibiotic use in care homes in the UK have
been based on point prevalence data or small data sets,
our results are more representative of the population
and less likely to be affected by seasonal variation.
A limitation of this study was that, although the phar-
macy chain is contracted to provide all prescriptions to
the care home chain, the data suggest that this does not
always happen in practice. To account for this, we con-
ducted two analyses with different inclusion criteria. The
main analysis included all residents from care homes
from which at least 75% of residents matched to phar-
macy data, and the sensitivity analysis included all resi-
dents (from any care home) that matched to at least one
pharmacy record. As expected, the sensitivity analysis
produced a slightly higher rate (2.81 antibiotic prescrip-
tions per resident year compared to 2.61 in the main
analysis), as this analysis excluded any residents who did
not have any prescriptions. However, both analyses may
still be underestimates of prescribing if many antibiotics
were dispensed from different pharmacies. Characteris-
tics of residents and care homes included and excluded
from the main analysis (additional file 2) were similar,
suggesting that factors associated with increased pre-
scribing are not due to bias in the data. Antibiotics dis-
pensed during hospital stays were also not captured in
this study.
Another limitation was that our analysis used data
from administrative care home systems that were not
designed for research. Information on temporary ab-
sences from homes, for example during hospital stays, or
temporary stays in homes funded by the local authority
were not available. Although we found increased anti-
biotic prescribing for residents with more probable co-
morbidities, this was based on a crude measure of repeat
prescriptions of non-antibiotic drugs. We did not have
information on specific co-morbidities or other medical
risk factors such as catheter use. Since the pharmacy
data does not include indication for the drug dispensed,
we were also not able to directly assess the appropriate-
ness of the antibiotic prescriptions. However, we per-
formed exploratory analyses examining how well the
antibiotic prescriptions matched the broad category of
infection reported in the care home incident monitoring
systems. This showed that, in general, antibiotics were of
expected classes for a given infection category. Further
work is needed to investigate prescribing patterns for
specific types of infection with or without microbio-
logical confirmation. Improved recording of care home
residency in primary and secondary care records, and
enhanced data collection within care homes, would en-
able these factors to be assessed in greater detail.
Table 3 Multivariable analysis of antibiotic prescribing
Variable Adjusted incidence rate ratio (95% CI)
Gender
Male Ref.
Female 1.03 (0.98–1.08)
Age
65–74 Ref.
75–84 0.96 (0.89–1.04)
85–94 0.99 (0.92–1.07)
95+ 1.11 (0.99–1.24)
Type of care
Residential Ref.
Nursing 1.21 (1.13–1.30)
Dementia
No Ref.
Yes 0.94 (0.89–1.00)
Respite care
No Ref.
Yes 1.12 (1.0–1.24)
Entered care home during study period
No Ref.
Yes 1.37 (1.30–1.44)
Status at end of study period
In home Ref.
Permanently Discharged 1.44 (1.32–1.57)
Died 1.58 (1.50–1.67)
Number of reported infection episodes during study
0 Ref.
1 1.44 (1.35–1.54)
More than 1 2.09 (1.96–2.24)
Number of BNF chapters with repeated prescriptions (excluding
antibiotics)
0–1 Ref.
2–4 1.94 (1.76–2.14)
5–7 2.38 (2.16–2.62)
8 or more 2.89 (2.54–3.28)
BNF British National Formulary, CI confidence interval; Ref. reference group
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Conclusions
In summary, this large-scale study has demonstrated
high rates of antibiotic use for residents of care homes
in the UK and a high degree of variation across homes.
Although antibiotics were mainly used for the most un-
well residents, the high variation in antibiotic use sug-
gests scope for improved stewardship. Our analysis has
identified potential targets for future stewardship inter-
ventions, but further work is needed to characterise the
drivers of prescribing in care homes to inform the devel-
opment of interventions that target the influences of
prescribing.
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